Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salud publica de Mexico·2026
Same author

Salud publica de Mexico·2026
Same author

Salud publica de Mexico·2026
Same author

Salud publica de Mexico·2026
Same author

Retail pharmacy clinics in Mexico: a commentary.

Lancet regional health. Americas·2026
Same author

Incident cases and healthcare costs of non-communicable diseases attributable to industrialized and total sugar sweetened beverage intake in Mexico.

BMC public health·2025
Same journal

Perimetric Outcomes of Melbourne Rapid Field Perimetry in Patients With Glaucoma: A Systematic Review and Meta-Analysis.

Journal of glaucoma·2026
Same journal

Rethinking Dry Eye and Ocular Surface Disease in Glaucoma: Pathophysiology, Diagnosis, and Management.

Journal of glaucoma·2026
Same journal

Outcome of Gonioscopy-Assisted Transluminal Trabeculotomy in Uveitic Glaucoma.

Journal of glaucoma·2026
Same journal

"Letter to the Editor: Myopic Shift Induced By Omidenepag Isopropyl 0.002% in Patients With Primary Open-Angle Glaucoma, Jan 2026.

Journal of glaucoma·2026
Same journal

Comparative Evaluation of Functional Aqueous Humor Outflow in Primary Open Angle Glaucoma versus Primary Angle Closure Glaucoma using Aqueous Angiography.

Journal of glaucoma·2026
Same journal

Patient and Neighborhood Factors Influencing Glaucoma Medication Adherence.

Journal of glaucoma·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.9K

Early Glaucoma Screening Using the Ibopamine Provocative Test.

Francisca Domínguez-Dueñas1, Leticia Plaza-Espinosa, Eva E Mundo-Fernández

  • 1*Department of Ophthalmology, National Rehabilitation Institute of Mexico, Medicine School of The National Autonomous University of Mexico †Ophthalmologic Clinic Anzures, Mexican Glaucoma Society, México City ‡The National Institute of Public Health of Mexico, México.

Journal of Glaucoma
|December 29, 2015
PubMed
Summary
This summary is machine-generated.

The ibopamine provocative test shows promise for early glaucoma detection. This test can identify individuals at higher risk for developing glaucoma, aiding in timely intervention.

More Related Videos

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.8K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Related Experiment Videos

Last Updated: Mar 28, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.9K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.8K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Area of Science:

  • Ophthalmology
  • Diagnostic Imaging
  • Clinical Trials

Background:

  • Early glaucoma detection is crucial for preventing irreversible vision loss.
  • The ibopamine provocative test is being investigated as a novel diagnostic tool.

Purpose of the Study:

  • To assess the diagnostic accuracy of the ibopamine provocative test for identifying early-stage glaucoma.
  • To evaluate the test's ability to discriminate between patients with and without early glaucoma.

Main Methods:

  • A cohort of 44 patients with suspicious optic discs and 37 controls underwent the ibopamine test.
  • Follow-up included glaucoma diagnostic tests, visual field assessments, and spectral-domain optical coherence tomography.

Main Results:

  • The ibopamine test demonstrated a sensitivity of 78.7% and a specificity of 71.6% for early glaucoma detection.
  • A positive ibopamine test was associated with an 8-fold increased risk of glaucoma, particularly in those with initial clinical suspicion.

Conclusions:

  • The ibopamine provocative test exhibits adequate diagnostic performance for detecting individuals at high risk of very early glaucoma.
  • Further research is warranted, but the ibopamine test holds promise as a valuable tool for early glaucoma diagnosis.